Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
10.33
-0.32 (-3.00%)
At close: Apr 29, 2025, 4:00 PM
10.01
-0.32 (-3.10%)
Pre-market: Apr 30, 2025, 5:03 AM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $241.63 million as of April 30, 2025. Its market cap has increased by 83.27% in one year.
Market Cap
241.63M
Enterprise Value
223.10M
1-Year Change
83.27%
Ranking
Category
Stock Price
$10.33
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $241.63M, an increase of 316.57%. That is a compound annual growth rate of 55.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 249.12M | 138.33% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.90B |
| Johnson & Johnson | 375.13B |
| UnitedHealth Group | 372.49B |
| AbbVie | 342.31B |
| Novo Nordisk | 287.71B |
| Abbott Laboratories | 226.33B |
| AstraZeneca | 218.53B |
| Novartis AG | 217.11B |